Cannabis sativa plants accumulate a suite of volatile biochemical compounds known as mono- and sesquiterpenes that determinethe characteristic scent of the plant, and contribute to its therapeutic properties in two ways. First, a 10-carbon terpene (amonoterpene) precursor makes up part of cannabinoid molecules, the key medicinal constituents of C. sativa plants. Second, someterpenes (e.g., geraniol and ?-caryophyllene) have potent medicinal properties of their own. There is therefore substantial interest inenhancing terpene production in cannabis plants.
In light of the national emphasis on climate change and clean growth, the federal and provincial governments have set key goals for developing and implementing globally sustainable production and consumption models in ways that improve the environment. The agricultural industries are seeking innovation and new technologies to develop more choices and alternatives in the raw materials for growing media, with considering environmental and economic sustainability as key driver.
Cannabis production requires highly manipulated, sterile growing conditions for optimum yields and product quality. However, plant performance, and in particular plant biosynthesis of metabolites such as cannabinoids, terpenes and alkaloids, depends on beneficial plant/microbial interactions. This project aims to develop a cannabis-specific bioinoculant of beneficial microbes to improve production yield and metabolic profile.
Join a thriving innovation ecosystem. Subscribe now